← All diseases
Liver, kidneys and digestion
Primary sclerosing cholangitis
Would you like to receive a message when there is new research on Primary sclerosing cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was investigated — and you'll get notified as soon as there is new research on Primary sclerosing cholangitis. View what Premium costs.
Publications and studies (1451)
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Overexpression of TNFα in TNF∆ARE+/- mice increases hepatic periportal inflammation and alters bile acid signaling in mice. (2024/11/25) ♡
- Computed tomography-based radiomics and body composition model for predicting hepatic decompensation. (2024/11/22) ♡
- Causal effect of primary sclerosing cholangitis on diffuse large B-cell lymphoma: A two-sample Mendelian randomized study. (2024/11/22) ♡
- Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform. (2024/11/19) ♡
- Esophagitis in a Post-Liver Transplant Patient: A Case of Cytomegalovirus and Herpes Simplex Virus-1 Coinfection. (2024/11/19) ♡
- Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. (2024/11/16) ♡
- Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative Colitis. (2024/11/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of primary sclerosing cholangitis: Current state-of-the-art. (2024/11/15) ♡
- Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGFβ-induced fibroinflammatory mediators in cholangiocytes. (2024/11/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. De Novo Kaposi Sarcoma in an HIV-Negative Liver Transplant Recipient With Ulcerative Colitis and Primary Sclerosing Cholangitis. (2024/11/12) ♡
- Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression. (2024/11/12) ♡
- Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD. (2024/11/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Liver transplantation in a child with sclerosing cholangitis due to Langerhans cell histiocytosis: a case report. (2024/11/07) ♡
- Racial Disparities in Inpatient Hospital Outcomes of Primary Sclerosing Cholangitis in United States: Nationwide Analysis. (2024/11/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute Viral Hepatitis E Presenting With Bell's Palsy and Acute Pancreatitis: A Case Report. (2024/11/07) ♡
- Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci. (2024/11/06) ♡
- Dissecting the genetic basis and mechanisms underlying the associations between multiple extrahepatic factors and autoimmune liver diseases. (2024/11/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Blockade of forkhead box protein O1 signaling alleviates primary sclerosing cholangitis-induced sarcopenia in mice model. (2024/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Replaced unclassified right hepatic artery arising from the celiac trunk: A case report. (2024/10/30) ♡
- [Clinical characteristics and prognosis analysis of patients with IgG4-related hepatobiliary-pancreatic disease]. (2024/10/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Skin as a Reflection of Gut Health: An Overview of Dermatological Manifestations in Primary Neoplastic and Autoimmune Gastrointestinal Disorders. (2024/10/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status That Responded to Pembrolizumab. (2024/10/09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN. (2024/10/03) ♡
- Mitochondrial DNA copy number and the risk of autoimmune diseases: A Mendelian randomization study with meta-analysis. (2024/10/02) ♡
- Caregiver-reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis. (2024/10/01) ♡
- Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium. (2024/10/01) ♡
- Adult Langerhans Cell Histiocytosis Presenting With Skin Lesions, Sclerosing Cholangitis and Pneumothorax. (2024/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. More Than Just Stool: Hypereosinophilic Syndrome Presenting as Persistent Diarrhea in a Patient With Ulcerative Colitis. (2024/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Mixed Cellular and Antibody-Mediated Rejection-A Rare yet Morbid Occurrence. (2024/09/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Surgical Outcomes in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis-Related Liver Disease. (2024/09/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Secondary Sclerosing Cholangitis (SSC): An Underrecognized Complication of Severe COVID-19 Pneumonitis. (2024/09/23) ♡
- Risk of comorbidity of autoimmune liver disease in patients with inflammatory bowel disease: A single-center case-control study in China. (2024/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5. (2024/09/01) ♡
- Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis. (2024/08/22) ♡
- Deep Learning-Based Prediction of Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis With Computed Tomography. (2024/07/31) ♡
- Loss of β-catenin reveals a role for glutathione in regulating oxidative stress during cholestatic liver disease. (2024/07/05) ♡
- Surrogate markers of bile duct disease progression in primary sclerosing cholangitis - A prospective study with repeated ERCP examinations. (2024/07/02) ♡
- Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of endoscopy in hepatology. (2024/07/01) ♡
- Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. (2024/07/01) ♡
- ECFS standards of care on CFTR-related disorders: Identification and care of the disorders. (2024/07/01) ♡
- Association Between MR Elastography Liver Stiffness and Histologic Liver Fibrosis in Children and Young Adults With Autoimmune Liver Disease. (2024/07/01) ♡
- Perihilar and Intrahepatic Cholangiocarcinoma after Resection: Clinicopathological Characteristics, Outcomes, and Implications for Addition of Chemoradiotherapy. (2024/07/01) ♡
- Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progression. (2024/06/29) ♡
- Distinct metabolomic and lipidomic profiles in serum samples of patients with primary sclerosing cholangitis. (2024/06/04) ♡
- Recurrent sclerosing cholangitis post-transplant: increased recurrence rates following re-transplantation. (2024/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Radiographic and endoscopic findings of checkpoint inhibitor cholangitis. (2024/06/01) ♡
- Good long-term outcomes of primary sclerosing cholangitis in childhood. (2024/05/25) ♡
- Biliary cast syndrome developed after treatment for acute cholangitis: progression to secondary sclerosing cholangitis. (2024/05/01) ♡
- Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. (2024/05/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.